excluded if the papers didn't fit the topic of interest. References cited in relevant papers were also examined and included if deemed important.
Discussion

History
Etiologic subgroups of ischemic stroke were first described in 1958 by the National Institute for Neurological Disorders and Blindness Report on cerebrovascular diseases. Ischemic stroke etiological subgroups were at that time designated "thrombosis with atherosclerosis", "cerebral embolism", "other causes" and "cerebral infarction of undetermined origin". The main goal of this initial report was stated by Milikan as follows: " Our ultimate objectives are to obtain greater clarity of thinking [in regard to cerebrovascular diseases], to compose a generally acceptable classification, to establish reliable criteria for diagnosis".
[6] Until the early 1970s ischemic stroke classification was mainly based on clinical grounds and autopsy studies. The 1970s were marked by the introduction of computerized brain tomography, the more frequent use of catheter angiography and by the well known description of lacunar syndromes by Miller Fischer. [7] [8] [9] The scarce available data of various clinical findings in different subtypes of stroke prompted a group of authors led by J.P. Mohr and L.R. Caplan to develop the Harvard Cooperative Stroke Registry. The Harvard Registry was the first prospective computer based registry on any medical condition. Patients with ischemic stroke were classified in three subgroups: "large artery thrombosis", "lacunar infarcts" and "embolism". [10, 11] In the meantime, 17 years after the initial NINDB communication, Milikan referring to ischemic stroke subtypes emphasized a perennial truth: "It continues to be evident that in such a complex set of clinical-pathophysiological phenomena some standard reference language or set of definitions should be used, or the literature of investigation will be uninterpretable". [12] The explosive growth of interest and knowledge about stroke was driven by the introduction of echocardiography, ambulatory cardiac rhythm monitoring, B-mode, continuous wave and pulsed-wave Doppler technology, as well as by high-energy bidirectional pulsed-Doppler systems for intracranial ultrasound, which were all available in the late 1980s. [13] The Stroke Data Bank Registry and later on, the TOAST project (Trial of ORG 10172 in Acute Ischemic Stroke) included the information achieved through these investigations in the criteria used for the etiologic classification of ischemic stroke. [14, 15] Nowadays, novel and refined imaging data, as well as prolonged rhythm monitoring techniques provide a vast amount of potential findings implicated in stroke etiology. With the more frequent implementation of international registries and wide-scale population studies, the need for reliable and comprehensive classification systems emerged. This led to the implementation of the updated TOAST classification (SSS-TOAST), the Causative Classification System (CCS) and of a comprehensive phenotypic ischemic stroke classification (ASCOD). [16] [17] [18] Different etiological classification systems are listed in Table 1. 3.2 Key concepts in stroke classification systems
Reliability and validity of classification systems
The subject of stroke classifications systems cannot be thoroughly approached without explaining the importance of reliability and validity. Reliability is the extent to which an experiment, test or measuring procedure yields the same results on repeated trials while validity is usually defined as the degree to which a research measures what it intends to measure. [19] The reliability of an ischemic stroke classification system refers to the reproducible classification of an index ischemic stroke by the same and by different examiners. It is thus, mainly defined by its interrater agreement (inter observer agreement) which is measured in any situation in which two or more observers evaluate the same thing. [19] The result is expressed as the kappa () coefficient, which is derived from the difference between the observed agreement compared to the agreement expected by chance alone. [20] There are no strict benchmarks for interpreting  values, a value of 0 usually indicating agreement equivalent to chance, while a value of 1 indicates perfect agreement. Kappa values between 0.61 and 0.8 are a measure for substantial interrater agreement while values above 0.81 are considered to show almost perfect agreement. [21] Assessment of the reliability of a classification system is a suitable measure to evaluate the message communicated between clinicians and researchers world-wide and an important determinant in the conception of clinical trials. Improvement of the reliability of a classification system from 0.5 to 0.8 might reduce the sample size of a clinical study by around 40%. [22] A classification system might be reliable if it yields the same results, irrespective of their validity.
Validity is examined by three separate points -criterion, construct and content. Criterion validity is measured with sensitivity, specificity and positive predictive value and implies a comparison with a "gold standard". [23] However stroke research lacks a gold standard for etiological diagnosis since there is a declining interest in autopsy studies. [24] Thus, most classification criteria rely on current diagnostic technologies and clinical patterns. Even with the use of modern ancillary tests and imaging techniques it is sometimes still debatable whether the mechanism underlying an ischemic stroke was embolic, atherothrombotic or hemodynamic. Construct validity is determined by comparing new classification systems with the old approved ones. Content validity measures the extent to which an instrument of measure includes all relevant dimensions of what it intends to measure. [23] 
Phenotypic versus causative classifications
Two main categories of classifications are currently being used for establishing the etiology of ischemic strokes. [3] Phenotypic classifications record all abnormal test findings, stratify them based on certain evidence grades without weighting towards the most likely cause. A phenotypic classification will assign a degree of probability for every possible stroke etiology. This feature makes phenotypic classifications like ASCOD[2], ASCO [25] , CCS [16] and Baltimore-Washington [26] ideal for large scale epidemiologic and genetic studies, as well as for ischemic stroke registries. [27] Causative classification systems assign patients with ischemic stroke in a single category based on available clinical, epidemiological and diagnostic data. These classifications usually rely on a set of criteria constructed with the help of an estimated risk of stroke attributed to different conditions in large population based studies. Thus, patients are classified in mutually exclusive categories, thereby reducing the number of subtypes. However, causality is not easily demonstrated. [28] Examples of causative systems include: TOAST [15] , CCS [16] and CISS [29] . An overview of the most used ischemic stroke classification systems is presented in Table 2 .
Etiology of ischemic stroke is often multifactorial and therefore an ideal ischemic stroke classification should both comprise all underlying pathologies that could potentially concur to an index event and emphasize the most likely etiological and pathophysiological mechanism. Phenotypic classifications are targeted towards describing the concurring underlying pathologies, without highlighting the most probable etiology, while causative classifications focus on establishing the most likely cause in a given patient, usually neglecting other associated diseases. A judicious use of this two different concepts might improve clinical research as well as daily clinical practice.
Main classification systems
TOAST Classification
The TOAST classification is the most widely used system for establishing ischemic stroke etiology. It was implemented in 1993 by Adams et al. in order to be used in the Trial of Org 10172 in Acute Stroke Treatment. [15] Although this trial was negative [30] , the TOAST classification was further used for a large number of epidemiologic [5] , intervention [30] , risk factor assessment [31, 32] and prognosis [33] studies for both stroke and transient ischemic attacks. [34] Furthermore, important ischemic stroke risk factors [35] , early and long term recurrence[4] as well as survival [35] were all found to differ between TOAST subtypes.
Being fairly simple to use, the TOAST classification provides the basic skeleton for ischemic stroke classification for clinicians and investigators alike. It is the most used classification system worldwide but many criticisms were raised regarding its reliability and validity. [24, 27] Despite the high reliability reported in the initial publication, the overall inter rater agreement for the TOAST system is now regarded as moderate. [36] However, reliability varies between subtypes, being high for atherosclerosis and cardioembolism (=0.80) but low for small vessel disease (=0.53) and strokes of undetermined cause (=0.40). [36] Reliability and validity were also shown to vary with the clinical expertise of the adjudicator and with stroke severity, agreement being usually lower for minor strokes. This might partially explain the above described differences in agreement. [37] Diagnostic accuracy and reliability for small vessel disease related infarcts is lowered by the strict criteria which restrict the classification process to lesions smaller than 15 mm and clinical features of lacunar syndromes. The 15 mm cut-off point was traditionally considered to be the upper size limit of lacunar infarcts, according to CT studies. However, MRI studies have shown that in the acute phase infarcts can go up to 20 mm on axial sections and therefore a strict size criterion is not valid. [38] Moreover, several studies have emphasized the limits of clinical lacunar syndromes in predicting small vessel disease related infarcts. [39, 40] In a study reported by Potter et al. 23% of patients with a cortical syndrome had an acute lacunar infarct, whereas 16% of patients with a lacunar syndrome had an acute cortical infarct. [39] These findings indicate that without magnetic resonance imaging the diagnosis of small vessel disease will unlikely be precise [41] and clinicians might overinflate the undetermined cause group by including here ischemic lesions >15mm that do not fit other categories. [42] The strict criteria for small vessel disease and the need to identify a mechanism might complicate the classification of subcortical infarcts even further. Studies in Asian patients have recently shown that branch artery occlusion associated with parental artery atherosclerotic plaques (without hemodynamic significance) frequently causes "single subcortical infarcts" that may be radiologically indistinguishable from "lacunes". [43] Beside the subcortical infarcts, the undetermined group might be also overinflated with the frequent (45-57%) detection of moderaterisk cardioembolic sources by transesophageal echocardiography. [44, 45] Thus, many patients might be unreasonably assigned to the undetermined category due to two identified causes. [3, 27] Another drawback of using the TOAST system is that in the clinical setting the work up is frequently stopped if one etiology is identified, many patients being classified with low level of confidence ("possible"). This can lead to overlooked etiologies and misguided treatment options.
Various modified TOAST classifications (SSS-TOAST [46] , CCS [16] ) have partially updated the classification criteria and solved the above mentioned problems but the complexity of the algorithms and the web-based requirements still impede the current use of these systems. This emphasizes the convenience and the simplicity of the original TOAST system, which are probably the most important qualities of this widely used classification.
Modified TOAST classifications
SSS-TOAST and CCS
The SSS-TOAST classification was the first published update of the TOAST classification. Its major aim was to improve reliability and update specific TOAST criteria according to recent clinical and technological advances. [46] This classification is composed of the same five major stroke categories of the TOAST classification but for each causative category the SSS-TOAST assigns three evidence grades: "evident", "probable" or "possible". Evidence grades were abstracted between evident and possible by using an arbitrary 2% annual or one-time primary stroke risk threshold. [46] In order to improve reliability, the threshold size for small vessel disease associated infarcts was increased from <15 mm to <20 mm, acknowledging the fact that acute infarction can be seen in subcortical areas on diffusion weighted imaging without fulfilling criteria for any other etiology. [47] As already mentioned, serial imaging studies suggest that acute diffusion weighted imaging overestimate the final infarct volume. [48] A comparison of the criteria for small vessel disease and large artery atherosclerosis related strokes in different classification systems is presented in Tables 3 and 4. One major change of the SSS-TOAST with respect to the original TOAST classification is that protruding arterial atheroma causing less than 50% stenosis is regarded as a possible source of large artery atherosclerosis related stroke provided that it is associated with recurrent clinical events and there is no evidence for other stroke mechanisms. Criteria defining medium and high risk cardioembolic sources were also revised, chronic myocardial infarction and congestive heart failure with low ejection fraction being regarded in SSS-TOAST as high-risk sources of cerebral embolism. Atrial flutter, bioprosthetic cardiac valves and nonbacterial thrombotic endocarditis were also listed as high risk sources of ischemic stroke, while mitral valve prolapse and cardiac wall motion abnormalities were completely removed from the original TOAST list. Another novelty of the SSS-TOAST classification is the definition of a distinct subtype of undetermined stroke termed "cryptogenic embolism".
Although this algorithm lowered the number of strokes included in the undetermined group to 4% and the interrater agreement of the classification was substantially improved (=0.78), the complicated system impeded the wide use of SSS-TOAST. As a consequence, the complex algorithm was computerized and the web-based variant was named the Causative Classification System (CCS). [16] CCS is an internet based questionnaire-style classification in which clinically relevant and ancillary testing data entry is performed in 5 steps. A printable summary page displays both causative and phenotypic details about stroke subtype. [16] CCS comprises few subtle changes of the initial SSS-TOAST classification. Most importantly, protruding arterial atheroma causing less than 50% stenosis, regarded in SSS-TOAST as a possible source of large artery disease stroke if associated with recurrent clinical events, is considered in CCS criteria for evident large artery atherosclerosis if accompanied by signs of plaques ulceration and thrombosis. [16] [46] Prior to the publication of the original CCS classification, Goldstein et al. managed to improve the reliability of the original TOAST classification system from 0.42-0.64 [36, 49] to 0.75 by also using a computer-based algorithm. However this improvement was largely attributed to the inclusion of patients with concurrent multiple mechanisms in the undetermined group. [50] On the contrary, the CCS computer-based algorithm classifies patients into specific etiologic subgroups without expanding the "undetermined" category, which accounts for only 4-6% of all cases. [16] 
The Spanish Classification system (GEECV/SEN)
GEECV/SEN is the classification system used by the Spanish Society of Neurology Study Group for Cerebrovascular Diseases. GEECV/SEN is a causative classification system that resembles TOAST and is easy and feasible to use. GEECV/SEN criteria classify strokes as atherothrombotic if either related to a stenosis of more than 50% in a corresponding large extra-or intracranial artery or if related to carotid plaques or a stenosis of less than <50% in a corresponding large artery in the presence of at least 2 predefined vascular risk factors. Criteria for small artery disease, cardioembolic and undetermined strokes are similar to TOAST. [51] 
The SPARKLE classification
The SPARKLE classification was published in 2014 and is a modified TOAST classification system. The major aim of the initial study group was to improve criteria for large vessel disease subtyping. Classification systems like TOAST and SSS-TOAST require more than 50% stenosis in the ipsilateral artery in order to attribute an ischemic stroke to large artery atherosclerosis. However, recent clinical data on atherosclerotic disease, as well as the often encountered clinical acumen, challenge this hypothesis. As a result, the SPARKLE system requires assessment of carotid plaque burden (through total plaque area measurement) and continuous transcranial Doppler monitoring for microemboli detection for classifying stroke in patients with <50% ipsilateral stenosis of relevant cerebral arteries. [52] Total plaque area is defined as the sum of the cross-sectional areas of all plaques measured in a longitudinal view in the common, internal or external carotid arteries on both sides. [53] [54] A total plaque area >1.19 cm 2 was found to be associated with a 19.5% greater -5 year risk of stroke, death or myocardial infarction [55] after adjustment for traditional coronary risk factors. These findings, initially published by Spence et al., were later replicated in different populations. [56, 57] Total plaque area can also be increased in patients without >50% stenosis of the cervical arteries. This counterintuitive finding can be elegantly explained by the initial compensatory enlargement of the atherosclerotic artery described by Glagov et al in 1987. [58] Traditional cardiovascular risk factors used for cardiovascular risk prediction do not adequately explain carotid plaque burden. [59] The concept of total plaque area is expected to revolutionize preventive cardiovascular medicine since Spence et al. found that a high Framingham Risk Score identified only 32% of patients who would experience cardiovascular events, whereas 77% of such events occurred among patients in the top quartile of total plaque area (3.4 times higher risk of stroke, death or myocardial infarction over 5 years). [60] As a consequence, the incorporation of carotid plaque measurement in a stroke classification system might lead to better awareness and treatment of atherosclerosis.
The initial reported intra-rater reliability was excellent and the interrater reliability was substantial. When compared to the CCS classification, the overall agreement was substantial, the major differences being observed in the assignment of large artery atherosclerosis, cardioembolism and strokes of undetermined cause. The SPARKLE system assigned more patients in the large artery disease and cardioembolic subgroups as compared with CCS. [61] However further studies are needed to evaluate the SPARKLE system in different populations.
Stroke Classifications in the Asian populations
The incidence and prevalence of the different cardiac, arterial, hemodynamic or systemic disorders which may underlie the emergence of an ischemic stroke vary among different populations. Classification systems have to be used world-wide, so it is of major importance to take into account the innate distribution of the different strokecausing diseases in different populations. [42, 62] Ischemic stroke subtype distribution varies in populations of different races and ethnicities because of the asymmetric prevalence of vascular risk factors as a result of different life-styles and intrinsic genetic clustering. [63] [64] [65] [66] In Western countries cardio-embolism is regarded as the most common cause of stroke since the prevalence of ischemic strokes attributed to large artery disease in these countries is steadily declining, probably due to the intensive medical management of atherosclerotic risk factors. [5, 67] On the contrary, in Asian populations large and small vessel diseases are the most frequent causes of stroke. [68] [69] [70] Furthermore, intracranial artery disease accounts for 30-50% of the ischemic stroke burden in Asia, whereas in North America it is incriminated in only 8-10% of cases. [71, 72] This discrepancy in etiology might blur the true incidence of different ischemic stroke subtypes in Asian patients when classified with unsuitable criteria.
Considering this propensity for intracranial vessel disease in the Asian population, an adequate classification system designated to be used in this part of the world should acknowledge the fact that "lacunar infarctions" due to branch occlusion or due to diseases like Moya-Moya, vasculitis and arterial dissections are much more frequent in Asian patients than in patients of European ancestry. [43, 73] Because of the high prevalence of intracranial atherosclerosis in Asia, several groups of authors modified the TOAST criteria in order to improve the detection of relevant intracranial large artery disease and to reduce strokes wrongly assigned to small vessel disease or with a deemed undetermined cause. The most important changes introduced by the first published papers on this topic concerned the classification of small subcortical ischemic strokes and strokes due to atherosclerotic disease. Thus, subcortical strokes of less than 20 mm are attributed to large artery disease and not to small vessel disease if an arterial stenosis, even <50%, in the parent artery is identified. Strokes are also attributed to large artery disease in the presence of ipsilateral intra or extracranial atherosclerosis and when no other cause is identified. [74, 75] 
Korean TOAST
The modified TOAST classification published by Han et al. [75] in 2007 was termed Korean TOAST. [29] Since atherosclerosis is presumed to account for the vast majority of strokes in Asian patients, Han and colleagues decided to include all patients with evidence of systemic atherosclerotic disease, in the absence of other possible causes, in a distinct group called "atherothrombosis". In this classification, the patients who meet the TOAST criteria for large artery atherosclerosis will constitute a subgroup of "atherothrombosis" called "atherosclerosis with significant stenosis of large arteries (ASLA)". [75] These changes increase the number of ischemic strokes attributed to atherothrombosis and decrease the number of strokes classified as undetermined. However, the widespread use of this classification system in different study populations is questionable, since the rationale for the creation of this wide group called "atherothrombosis" relies on a study in which a small number of Asian patients were classified according to TOAST criteria and further on screened for systemic atherosclerosis and cardiovascular events. [76] Although in the original study in which the Korean TOAST classification was implemented the interrater agreement was excellent (=0.82), the  value for the TOAST classification was also significantly higher than previously reported (=0.79). [77] 
CISS
CISS is a two step classification system that intends to define both the etiological as well as the pathophysiological ischemic stroke mechanism. Similar to the Korean authors that implemented the previously discussed modified TOAST classification, the CISS authors redefined the large artery atherosclerosis criteria and created a new concept termed "penetrating artery disease" instead of small vessel disease. [29] Both the CISS and the Korean TOAST criteria attribute a large number of strokes to atherothrombosis. The rationale that underlies these modified criteria is the available evidence suggesting that the degree of stenosis is not the sole predictor of stroke recurrence, the total plaque burden [78] and plaque stability [79] being also relevant. However, the importance of unstable plaques in stroke medicine is still a matter of debate. The concept of "vulnerable plaques" was first introduced in the setting of coronary syndromes where ruptured plaques with thin fibrous caps were shown to be often associated with acute infarctions. [80, 81] Nevertheless, the importance of this concept for the cerebral circulation is debatable, since the pathophysiological mechanism of stroke related to large artery disease is largely different from that determining myocardial infarction. Even if it's tempting to assume that isolated, non-stenosing unstable plaques carry a higher risk of stroke as compared to the stable ones, clear evidence derived from large population-based studies is scarce. Future results of the currently ongoing studies on this subject (CAPIAS, CARE-II, PARISK) will probably offer valuable insight about the risk of stroke in this clinical setting, thus clarifying the veracity of CISS and Korean TOAST classification criteria. [82] [83] [84] 
The A-S-C-O and A-S-C-O-D classifications
In 2009 Amarenco et al. published the A-S-C-O phenotypic classification. [25] A-S-C-O stands for: atherosclerosis; small vessel disease; cardiac sources; other causes. This classification describes all concurrent pathologies that can potentially lead to an ischemic stroke in a given patient with the ultimate goal to answer the broad question: "why could this patient suffer a stroke?" and not "why did this patient suffer the index stroke?".
Although fairly complex at first sight, the A-S-C-O system actually resembles daily medical reasoning. It fits perfectly into the current clinical practice by gradually answering the questions that every stroke neurologist should raise in front of every patient: Which diagnostic tests should I use for accurate identification of stroke etiology? Which are the underlying patient's diseases that could lead to an ischemic stroke? Which is potentially causal for the index stroke? Which is his future risk of stroke? Which is the best secondary prevention strategy?
This phenotypic classification was revised in 2013 and termed A-S-C-O-D.
[2] The new system introduced arterial dissection as a "stand alone" category (due to the high prevalence of this finding in young patients with ischemic stroke) and simplified the methods of classification by incorporating the levels of diagnostic evidence into the grades of the disease. The threshold of significance for carotid artery stenosis and intracranial artery stenosis was decreased from 70% to 50%.
A major advantage of the ASCOD grading system over the TOAST classification is the very low proportion of ischemic strokes in which no ASCOD evidence grades of 1, 2 or 3 can be identified. [85] As a consequence, the proportion of strokes of undetermined etiology despite extensive work-up significantly diminishes. Even if in many cases the causality between the identified diseases in each category and the index stroke cannot be certainly proven (grades 2 and 3), the ASCOD phenotype gives an overview of all potential factors that might concur to future ischemic cerebrovascular events, thus offering valuable information for guiding treatment strategies.
Using ASCOD criteria a large overlap between the 3 main etiologies (cardiac disease, large artery disease and small vessel disease) was identified. Therefore, from a practical point of view identified pathologies should all be considered when managing the patient regardless of which is judged to be causal for the index stroke. Atherosclerotic disease, even if not causally related, is identified in 90% of patients, highlighting the importance of meticulous atherosclerotic risk factor control in all ischemic stroke patients. [17] Although more complicated to use in daily clinical practice than the TOAST classification, the A-S-C-O-D system is a useful tool in the era of national registries and large epidemiological studies. This rigorous classification algorithm can be of valuable use in the process of selecting patients with specific types of cerebrovascular diseases. For example, regardless of the presumed etiology of an ischemic stroke all patients with concurrent relevant small vessel disease will be classified at least S 3 . Since all these patients can be selected for inclusion in an epidemiological study focusing on risk factors for small vessel disease, the number of patients selected from a hospital-based or national registry will be greatly enhanced. 
Comparisons between different classification systems
The need for a reliable and valid stroke classification system is of utmost importance for stroke research and clinical practice. As long as etiologic classification of stroke will be subject to variation in different parts of the world, studies will continue to yield puzzling results, because correct data interpretation requires a "standard language" and "standard criteria". The components of focused clinical questions in modern evidence based medicine are frequently described using the acronym 'PICO' and its various variants, where P stands for population, I for intervention, C for comparison and O for outcome. Consequently, without homogenously defined "populations of patients with a problem" clinical decision making will unlikely benefit from the results of the vast amount of studies published nowadays. [89] A major goal of all ischemic stroke classification systems developed after the initial publication of TOAST classification was to minimize the category of undetermined strokes without lowering the accuracy of classification for other stroke categories. In TOAST, strokes with more than one possible cause are grouped together with strokes of unknown etiology due to incomplete work-up and the ones of unknown etiology despite extensive evaluation in the broad group of strokes of undetermined cause, which comprises around 25% of all ischemic strokes. Since minimal work-up requirements for each TOAST category are not clearly stated, in daily clinical practice the percentage of strokes of undetermined etiology will depend on the physician's perseverance to investigate a patient and on the availability of diagnostic tools.
truly undetermined stroke is supposed to have a phenotype with all 5 ASCOD categories graded "0" or whether the phenotypes including also grades of "3" should be placed under the same umbrella.
In SSS-TOAST and CCS, undetermined strokes are defined on the basis of well established criteria, which are completely different from the original TOAST ones. This change, together with the modified definition for the other stroke categories, led to a decrease of strokes classified as undetermined to 8-13% of all ischemic strokes. [90] In SSS-TOAST and CCS, a distinct category of undetermined stroke is stroke attributed to "cryptogenic embolism", which is probably the first official designation of the clinical construct published by the CS/ESUS International Working Group in 2014 and named embolic stroke of undetermined source (ESUS). [91] The concept of ESUS is more a mechanism oriented definition than a causative one, since embolism is considered to be the sole stroke mechanism but the emboli can arise from a multitude of both cardiac and vascular sources.
Occult paroxysmal atrial fibrillation (AF) is probably the most commonly suspected ESUS etiology and consequently several studies addressed this topic over the past years. The rate of AF detection in patients with strokes of unknown etiology after initial diagnostic evaluation varied among different studies between 3.2 and 30% depending on the method and duration of monitoring. [92] However, the definite causal link between paroxysmal atrial fibrillation detected during follow-up and a preceding stroke is still being questioned for several reasons. First, different studies investigating the temporal relationship between subclinical AF detection and ischemic stroke in patients with implantable pacemakers and defibrillators proved that in only a minority of cases AF occurs in the 30 days preceding stroke onset. [93] [94] [95] In ASSERT study, subclinical episodes of AF were detected in 35% of patients who experienced an ischemic stroke or systemic embolism during follow-up but in only 8% of cases these episodes were detected in the 30 days preceding the embolic event and other studies showed similar results. [96] Second, although AF is defined by consensus as an irregular heart rhythm with specific features, lasting for more than 30 seconds, a few studies have also quantified the detection of brief episodes of AF lasting less than 30 seconds in stroke patients and reported that more than half of the AF episodes detected by means of different continuous monitoring devices are episodes lasting less than 30 seconds. [97] [98] [99] Since the duration of AF needed for thrombus formation in the left atrial appendage is much longer, it is questionable whether these brief AF episodes lasting less than 30 seconds can be direct determinants of emboli formation or are rather biomarkers for more prolonged AF episodes of sufficient duration to result in cardiogenic embolization. [99] It has also been hypothesized these subclinical episodes of AF may be indicators of the emerging concept of atrial cardiopathy, which may be by itself associated with an increased risk of stroke. [100] Third, the clinical relevance of very short episodes of AF detected by long term cardiac rhythm monitoring is further questioned by several studies showing that brief episodes of AF are fairly common in stroke survivors, irrespective of stroke subtype. [101] Another entity that has not encountered a clear place in stroke classification systems (see Table 5 ), but is listed among ESUS etiologies, is PFO. Paradoxical embolism is the main postulated mechanism of PFO related strokes but in situ thrombosis and propensity for cardiac arrhythmias have also been proposed. [102] The increased availability of transesophageal echography over the last decade initially generated a true "epidemy" of PFO-related strokes, since PFO can be detected in up to 58% of patients with cryptogenic strokes. [103] Later on, several PFO characteristics together with clinical and imaging features associated with a high risk of thromboembolism have been suggested. In 2012, RoPE investigators proved that risk of stroke recurrence in patients in which PFO is deemed to be causal is actually very low and provided a score to help distinguishing between stroke-related and incidental PFO in cryptogenic stroke patients. [104] Since the causal relationship between PFO and stroke is difficult to prove in the majority of cases, stroke classification systems usually list PFO as a low-risk cardioembolic source without further comments. ASCOD and SPARKLE criteria provide more comprehensive approaches to classify ischemic stroke when PFO is identified but further refinement is probably needed. [2, 61] Another pathology considered to potentially underlie an ESUS, aortic arch atherosclerosis, is differently approached by currently used ischemic stroke classifications and thus represents a potential source of disagreement between these systems. Aortic arch disease is not mentioned at all in TOAST. In modified TOAST classifications (SSS-TOAST and CCS) and SPARKLE, complex aortic atheroma is regarded as a low-risk source of cardioembolism because ischemic strokes related to this etiology share similar clinical and neuroimaging features with strokes attributable to cardiac sources of embolism, whereas ASCO/ASCOD and Asian classifications list aortic plaques of more than 4 mm as criteria of large artery atherosclerosis.[2, 16, 46, 61, 75] From a practical perspective, the optimal treatment strategy in patients with ESUS is currently a matter of debate but the soon expected results of Respect-ESUS [105] , Navigate-ESUS [106] , Atticus [107] will probably shed more light into this very important topic. Moreover, if anticoagulant drugs will prove their superiority over antiplatelets, the ESUS concept will become of significant importance in daily clinical practice and consequently ischemic stroke classifications will have to be modified in order to incorporate this concept as a stand alone stroke category.
An important argument for the importance of reliability in stroke research is made by the NINDS SiGN study, the largest study of ischemic stroke subtyping published so far. [108] The SiGN consortium retrospectively classified 16954 patients from 12 U.S. and 11 European studies using the Causative Classification System. The stroke classification process was meticulously performed in order to minimize variability between centers. [90, 108] This study underlined the importance of a standardized investigation practice when classifying ischemic stroke for study purposes. It identified important differences in the distribution of phenotypic and causative subgroups in patients investigated by variable means (i.e. large artery disease was classified as evident in 21% of the fully investigated population as opposed to 11% of those with routine investigations). [90] Important advances in stroke work-up have been made during the two decades that followed the initial publication of the TOAST classification, but the costs associated to ischemic stroke work-up should also materialize in valid classification systems. A recent study that investigated the validity of ischemic stroke classifications showed that CCS, TOAST and ASCO systems generate distinct subtypes with different clinical characteristics, all systems providing significant discrimination for the validation variables tested (90-day survival, NIHSS score at admission, admission infarct volume). [109] The area under curve for 90-days stroke recurrence was higher for CCS than for ASCO and TOAST (AUC 0.71 vs. 0.66 vs. 0.61), but the tested validation variables significantly differed between etiological subtypes for all three classification systems. Although far from perfect, the CCS classification might therefore be more suitable for etiological subtype assessment in large stroke clinical trials. [109] The largest analysis of the agreement between the TOAST and CCS classifications was also published by the SiGN consortium and not unexpectedly (different classification criteria) a moderate overall agreement with wide variability in different study sites (from 28%-90%) was reported. The authors of the study ironically concluded that "basically the two systems classify stroke in different categories, but unfortunately they are named the same". These findings should lead to caution when interpreting comparisons between studies that use different classification criteria. [110] Previous comparisons between TOAST, CCS, and ASCO showed good overall agreement between all classification systems. [111] However, when comparing categories graded ASCO "1" with corresponding TOAST categories fewer patients were classified as small artery disease and more as large artery atherosclerosis. Agreement between categories graded as potentially causal or evident in ASCO and CCS ranged from good to excellent. CCS assigned fewer patients to the undetermined group while ASCO better characterized patients classified as TOASTundetermined. Another study proved that main mismatches in classifying strokes by either TOAST or ASCO/ASCOD criteria were accounted by the fact that the TOAST system classifies strokes in patients with PFO as cardioembolic and strokes in patients with competing etiologies in the undetermined group. [85] CISS classification system [29] was recently compared with TOAST in an Asian trial involving mainly minor strokes. Interagreement between the two classification systems was only moderate. CISS assigned 77% less patients than TOAST in the undetermined group and 79% more patients in the large artery atherosclerosis group. [112] These differences can be explained by the markedly different CISS criteria for small vessel disease and large artery atherosclerosis as compared to TOAST. These differences in classification criteria are of major importance when interpreting results of clinical trials conducted in Asian patients and further emphasize the importance of an unique, reliable and valid ischemic stroke classification system in all major therapeutic trials.
Conclusions
Despite major technological advances in ischemic stroke diagnostic techniques, our current understanding of stroke mechanisms and etiology continues to remain unclear in a significant percent of patients. Since a plethora of classification systems are nowadays used for ischemic stroke subtype assessment, clinicians and researchers should carefully weigh the advantages and disadvantages of each of them, in order to choose the most suitable classification for their individual purposes. Development of modern phenotypic classification systems has been a major breakthrough during the last decade but their reliability and validity is far from perfect and further worldwide research is needed in order to achieve the so much needed "standard reference language". [4] J.K. Lovett, A.J. Coull, P.M. Rothwell, Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies., Neurology. 62 (2004) Clinical findings, neuroimaging data suggestive for LAA but other studies are not done.
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(1) Clinical and brain imaging findings of significant (more than 50%) stenosis or occlusion of a major brain artery, presumably due to atherosclerosis.
(2) A history of intermittent claudication, TIAs in the same vascular territory, a carotid bruit or diminished pulses helps support the clinical diagnosis. (3) Cortical or cerebellar lesions and brain stem or subcortical hemispheric infarcts > 1.5 cm in diameter on CT or MRI are considered to be of potential LAA origin. SSS -TOAST Evident Probable Possible (1) Occlusive or stenotic (≥ 50% diameter reduction) vascular disease judged to be due to atherosclerosis in the clinically relevant I/E arteries; and (2) Absence of acute infarction in vascular territories other than the stenotic or occluded artery.
(1) Prior history of one or more TMBs, TIAs or stroke from the territory of index artery affected by atherosclerosis within the last month; or (2) Evidence of near-occlusive stenosis or nonchronic occlusion judged to be due to atherosclerosis in the clinically relevant I/E arteries (except for the vertebral arteries); or (3) Ipsilateral and unilateral internal watershed infarctions or multiple, temporally separate, infarctions exclusively within the territory of the affected artery.
(1) Presence of an atherosclerotic plaque protruding into the lumen and causing mild stenosis (<50%) in a clinically relevant I/E artery and prior history of ≥ 2 TMBs, TIAs or strokes from the territory of index artery affected by atherosclerosis, at least one event within the last month; or (2) Evidence for evident LAA in the absence of complete diagnostic investigation for other mechanisms
CCS
Evident Probable Possible (1) Occlusive or stenotic ( ≥ 50% diameter reduction or <50% diameter reduction with plaque ulceration or thrombosis) vascular disease judged to be caused by atherosclerosis in the clinically relevant I/E arteries; and (2) Absence of acute infarction in vascular territories other than the stenotic or occluded artery.
Same as SSS -TOAST
(1) Presence of an atherosclerotic plaque protruding into the lumen and causing mild stenosis (<50%) in the absence of any detectable plaque ulceration or thrombosis in a clinically relevant I/E artery and history of ≥ 2 TMBs, TIAs or stroke from the territory of index artery affected by atherosclerosis, at least one event within the last month; or (2) Evidence for evident LAA in the absence of complete diagnostic investigation for other mechanisms ASCO A1 (Definitely a potential cause of stroke ) A2 (Causality uncertain) A3 (Unlikely a direct cause of stroke but disease present) (1) Atherosclerotic stenosis 70-99% in an I/E artery supplying the ischemic field diagnosed by level A or B evidence; or (2) Atherosclerotic stenosis <70% in an I/E artery supplying the ischemic field with attached luminal thrombus diagnosed by level A or B evidence; or (3) Mobile thrombus in the aortic arch; or (4) Occlusion with imaging evidence of atherosclerosis in an I/E artery supplying the ischemic field.
(1) Atherosclerotic stenosis 70-99% in an I/E artery supplying the ischemic field diagnosed by level C evidence; or (2) Atherosclerotic stenosis<70% in an I/E artery supplying the ischemic field with attached luminal thrombus diagnosed by level C evidence; or (3) Aortic arch plaques >4 mm in thickness without a mobile component.
(1) Presence of carotid or vertebral artery plaque without stenosis; or (2) Aortic arch plaque <4 mm; or (3) Stenosis (any degree) in a brain artery, not supplying the infarct area (e.g. contralateral side or opposite circulation); or (4) History of myocardial infarction or coronary revascularization or peripheral arterial disease. Clinical findings, neuroimaging data suggest specific subtypes but other studies are not done.
(1) Traditional clinical lacunar syndrome with no evidence of cortical dysfunction. Diabetes and hypertension are supportive.
(2) Normal CT/MRI examination or relevant brain stem or a subcortical hemispheric lesion a diameter of less than 1.5 cm. (3) Absent cardiac sources of embolism. Exclusion of a stenosis of >50% in a ipsilateral major artery.
SSS -TOAST
Evident Probable Possible Imaging evidence of a single clinically relevant acute infarction less than 20mm in greatest diameter within the penetrating arteries, in the absence of any other pathology in the parent artery at the site of the origin of the penetrating artery.
Clinical syndrome is not taken into consideration.
The presence of stereotypic lacunar TIAs within the past week.
(1) Presenting with a classical lacunar syndrome in the absence of imaging that is sensitive enough to detect small infarctions; or (2) Evidence for evident small artery occlusion in the absence of complete diagnostic investigation for other mechanisms (1) Typical lacunar syndrome; and (2) Presence of another evident cause of stroke with a mechanism of disease that cannot explain the presenting symptoms and signs (1) Clinical evidence of a lacunar syndrome with normal brain imaging; and (2) Presence of another possible cause of stroke/TIA unrelated with presenting stroke/TIA in terms of time to symptom onset and mechanism of disease CISS Evidence grades not applicable (1) Acute isolated infarct in clinically relevant territory of one penetrating artery, regardless of the size of infarct; and (2) No evidence of atherosclerotic plaque (detected by HR-MRI) or any degree of stenosis in the parent artery (detected by TCD, MRA, CTA, or DSA); and (3) Other plausible causes excluded.
KOREAN-TOAST Evidence grades not applicable
(1) A single ischemic lesion occurring in a single perforating arterial territory. Strict size criterion not given but suggested to be usually smaller than 2 cm; and (2) Normal angiographic studies of the relevant arteries. 
